Infected blood inquiry: Five things we have learned

1. The scale of the tragedy: The inquiry has revealed the devastating impact of infected blood products on thousands of people in the UK, many of whom have suffered disabilities or lost their lives as a result.

2. Government negligence: It has become clear that government officials were aware of the risks associated with contaminated blood products as early as the 1970s, but failed to take adequate action to protect the public.

3. The role of pharmaceutical companies: The inquiry has shed light on the role of pharmaceutical companies in the distribution of tainted blood products, raising questions about their responsibility in the crisis.

4. The impact on families: Families of those affected by contaminated blood products have shared heartbreaking stories of loss, grief, and anger, highlighting the ongoing emotional toll of the scandal.

5. Calls for justice and accountability: The inquiry has sparked calls for justice for the victims and their families, as well as demands for greater accountability from the government and healthcare institutions involved in the scandal.